183 related articles for article (PubMed ID: 34159752)
21. Differences in microRNA expression between melanoma and healthy adjacent skin.
Aksenenko M; Palkina N; Komina A; Tashireva L; Ruksha T
BMC Dermatol; 2019 Jan; 19(1):1. PubMed ID: 30611259
[TBL] [Abstract][Full Text] [Related]
22. Transcriptome analysis reveals the link between lncRNA-mRNA co-expression network and tumor immune microenvironment and overall survival in head and neck squamous cell carcinoma.
Zhong Z; Hong M; Chen X; Xi Y; Xu Y; Kong D; Deng J; Li Y; Hu R; Sun C; Liang J
BMC Med Genomics; 2020 Mar; 13(1):57. PubMed ID: 32228580
[TBL] [Abstract][Full Text] [Related]
23. A novel lncRNA-miRNA-mRNA competitive endogenous RNA network for uveal melanoma prognosis constructed by weighted gene co-expression network analysis.
Yu H; Cheng Y; Li W; Li Z; Wu P; Qiu S; Zeng B; Huang B
Life Sci; 2020 Nov; 260():118409. PubMed ID: 32926921
[TBL] [Abstract][Full Text] [Related]
24. NEAT1/miR-200b-3p/SMAD2 axis promotes progression of melanoma.
Zhou WJ; Wang HY; Zhang J; Dai HY; Yao ZX; Zheng Z; Meng-Yan S; Wu K
Aging (Albany NY); 2020 Nov; 12(22):22759-22775. PubMed ID: 33202380
[TBL] [Abstract][Full Text] [Related]
25. Immune Infiltration-Related ceRNA Network Revealing Potential Biomarkers for Prognosis of Head and Neck Squamous Cell Carcinoma.
Zhao S; Peng M; Wang Z; Cao J; Zhang X; Yu R; Huang T; Lian W
Dis Markers; 2022; 2022():1014347. PubMed ID: 36097539
[TBL] [Abstract][Full Text] [Related]
26. Construction of lncRNA TYMSOS/hsa-miR-101-3p/CEP55 and TYMSOS/hsa-miR-195-5p/CHEK1 Axis in Non-small Cell Lung Cancer.
Ji L; Yang T; Liu M; Li J; Si Q; Wang Y; Liu J; Dai L
Biochem Genet; 2023 Jun; 61(3):995-1014. PubMed ID: 36352081
[TBL] [Abstract][Full Text] [Related]
27. Integrative analysis of immune microenvironment-related CeRNA regulatory axis in gastric cancer.
Chen J; Chen JG; Sun B; Wu JH; Du CY
Math Biosci Eng; 2020 Jun; 17(4):3953-3971. PubMed ID: 32987562
[TBL] [Abstract][Full Text] [Related]
28. Dysregulation of SNHG16(lncRNA)-Hsa-Let-7b-5p(miRNA)-TUBB4A (mRNA) Pathway Fuels Progression of Skin Cutaneous Melanoma.
Chen G; Yan J
Curr Protein Pept Sci; 2022; 23(11):791-809. PubMed ID: 36173063
[TBL] [Abstract][Full Text] [Related]
29. A Competing Endogenous RNA Network Reveals Novel lncRNA, miRNA and mRNA Biomarkers With Diagnostic and Prognostic Value for Early Breast Cancer.
Luo ZB; Lai GE; Jiang T; Cao CL; Peng T; Liu FE
Technol Cancer Res Treat; 2020; 19():1533033820983293. PubMed ID: 33371806
[TBL] [Abstract][Full Text] [Related]
30. miRNA and mRNA expression profiling reveals potential biomarkers for metastatic cutaneous melanoma.
Wang J; Tao Y; Bian Q
Expert Rev Anticancer Ther; 2021 May; 21(5):557-567. PubMed ID: 33504224
[No Abstract] [Full Text] [Related]
31. Long noncoding RNA ZFAS1 promotes tumorigenesis through regulation of miR-150-5p/RAB9A in melanoma.
Liang L; Zhang Z; Qin X; Gao Y; Zhao P; Liu J; Zeng W
Melanoma Res; 2019 Dec; 29(6):569-581. PubMed ID: 30889053
[TBL] [Abstract][Full Text] [Related]
32. Long noncoding RNA ILF3-AS1 promotes cell proliferation, migration, and invasion via negatively regulating miR-200b/a/429 in melanoma.
Chen X; Liu S; Zhao X; Ma X; Gao G; Yu L; Yan D; Dong H; Sun W
Biosci Rep; 2017 Dec; 37(6):. PubMed ID: 28935763
[TBL] [Abstract][Full Text] [Related]
33. Expression Patterns of microRNAs and Associated Target Genes in Ulcerated Primary Cutaneous Melanoma.
DiVincenzo MJ; Schwarz E; Ren C; Barricklow Z; Moufawad M; Yu L; Fadda P; Angell C; Sun S; Howard JH; Chung C; Slingluff C; Gru AA; Kendra K; Carson WE
J Invest Dermatol; 2023 Apr; 143(4):630-638.e3. PubMed ID: 36202232
[TBL] [Abstract][Full Text] [Related]
34. Exploring the Molecular Mechanisms of Pterygium by Constructing lncRNA-miRNA-mRNA Regulatory Network.
Xu N; Cui Y; Dong J; Huang L
Invest Ophthalmol Vis Sci; 2020 Jul; 61(8):12. PubMed ID: 32645133
[TBL] [Abstract][Full Text] [Related]
35. Differential Expression of Immune-Regulatory Genes Associated with PD-L1 Display in Melanoma: Implications for PD-1 Pathway Blockade.
Taube JM; Young GD; McMiller TL; Chen S; Salas JT; Pritchard TS; Xu H; Meeker AK; Fan J; Cheadle C; Berger AE; Pardoll DM; Topalian SL
Clin Cancer Res; 2015 Sep; 21(17):3969-76. PubMed ID: 25944800
[TBL] [Abstract][Full Text] [Related]
36. Regulation of RUNX3 tumor suppressor gene expression in cutaneous melanoma.
Kitago M; Martinez SR; Nakamura T; Sim MS; Hoon DS
Clin Cancer Res; 2009 May; 15(9):2988-94. PubMed ID: 19336521
[TBL] [Abstract][Full Text] [Related]
37. Comprehensive analysis of a cuproptosis-related ceRNA network implicates a potential endocrine therapy resistance mechanism in ER-positive breast cancer.
Zhang D; Lu W; Zhuo Z; Wang Y; Zhang W; Zhang M
BMC Med Genomics; 2023 May; 16(1):96. PubMed ID: 37143115
[TBL] [Abstract][Full Text] [Related]
38. Long non-coding RNA AFAP1-AS1 accelerates the progression of melanoma by targeting miR-653-5p/RAI14 axis.
Liu F; Hu L; Pei Y; Zheng K; Wang W; Li S; Qiu E; Shang G; Zhang J; Zhang X
BMC Cancer; 2020 Mar; 20(1):258. PubMed ID: 32228518
[TBL] [Abstract][Full Text] [Related]
39. Construction of lncRNA-miRNA-mRNA regulatory network in severe asthmatic bronchial epithelial cells: A bioinformatics study.
Fan M; Song W; Hao Z; Zhang J; Li Y; Fu J
Medicine (Baltimore); 2023 Sep; 102(35):e34749. PubMed ID: 37657025
[TBL] [Abstract][Full Text] [Related]
40. Comprehensive upstream and downstream regulatory analyses identify miR-675-3p as a potential prognostic biomarker in melanoma.
Zhao CC; Guo H; Wang Y; Li JH
Hum Cell; 2021 Mar; 34(2):654-666. PubMed ID: 33400243
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
